$PRLD

$3.88 +$0.18 (4.86%) Close

$PRLD Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Ownership

13F as of Q2 2026 · 79.8M shares outstanding

Who owns PRLD?

By type of holder

Institutions 62.2% Insiders 25.4% Everyone else 12.4%

Concentration Top 10 holders own 111.5%

Orbimed Advisors LLC 17.2% · Orbimed Capital GP Vi LLC 14.8%

Institutional ownership

62.2%

+23.6 pts vs last qtr

Institutional holders

+20 vs last qtr

Net shares bought

+18.8M

by institutions in Q2 2026

New / sold out

34 / 14

positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026

Ra Capital Management, L.P. NEW +6.5M
Soleus Capital Management, L.P. NEW +3.4M

Biggest sellers in Q2 2026

EcoR1 Capital, LLC SOLD OUT −947.0K
Susquehanna International Group, LLP SOLD OUT −267.8K

Who is planning to sell?

No insider has filed a notice of proposed sale (Form 144) for Prelude Therapeutics Incorporated in the last 12 months.

Is your stake being diluted?

Diluted share count, FY2021–FY2025

+67.1%

+13.70% a year

Each share's claim on the business

−40.2%

shrank without buying or selling a share

Spent on buybacks vs paid in stock

— vs $105M

over 5 fiscal years

Diluted shares, split-adjusted

Buybacks Stock-based comp

How patient are the owners?

Institutional shares by how long they've been held

5+ years62% 3–5 years3% 1–3 years3% Under 1 year32%

Quarterly turnover

37.4%

of institutional shares changed hands

Top 10 managers, median time held

4.5 years

Super Investors

Investment managers reporting PRLD on Form 13F

Holder	Shares	% of company	Change vs last qtr	Held since	% of their book
OA Orbimed Advisors LLC 13D · 16.0%	13.7M	17.20%	+2.8M (+25.8%)	≤2021	1.4%
Shares held by quarter Peak holding13.7M (Q2'26) Change over 8 quarters+2.8M Share of the company17.200% Disclosed stake13D · 16.0% Orbimed Advisors LLC's full portfolio →
BB Baker Bros. Advisors LP 13D · 15.5%	10.1M	12.69%	Unchanged	≤2021	0.3%
Shares held by quarter Peak holding10.1M (Q3'24) Change over 8 quarters0 Share of the company12.690% Disclosed stake13D · 15.5% Baker Bros. Advisors LP's full portfolio →

Orbimed Advisors LLC

13D · 16.0%

13.7M

% of company

17.20%

Change vs last qtr

+2.8M (+25.8%)

Held since

≤2021

Baker Bros. Advisors LP

13D · 15.5%

10.1M

% of company

12.69%

Change vs last qtr

Unchanged

Held since

≤2021

28 more super investors behind a free account

See every manager holding Prelude Therapeutics Incorporated, how their position has changed, and how long they've held it.

Institutional Funds

Mutual funds and ETFs reporting PRLD on Form N-PORT; together they hold 5.5% of the company

Fund	Position value	Shares	% of company	% of the fund	As of
VT Vanguard Total Stock Market Index Fund Vanguard Index Funds	$8.07M	1.5M	1.90%	0.00%	June 30, 2026
IR iShares Russell 2000 ETF iShares Trust	$3.51M	658.0K	0.82%	0.00%	June 30, 2026

Vanguard Total Stock Market Index Fund

Vanguard Index Funds

Position value

$8.07M

% of company

1.90%

% of the fund

0.00%

As of

June 30, 2026

iShares Russell 2000 ETF

iShares Trust

Position value

$3.51M

% of company

0.82%

% of the fund

0.00%

As of

June 30, 2026

23 more funds behind a free account

See every fund holding Prelude Therapeutics Incorporated and how much of the fund the position is.

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G

Holder	Shares	% of company	Change vs last qtr	8 quarters	Held since	% of their book
OC Orbimed Capital GP Vi LLC 5%+ holder 13D · 14.6%	11.8M	14.80%	—	—	—	—
This holder reports through Schedule 13D/G, not a quarterly 13F. Share of the company14.800% Disclosed stake13D · 14.6% View the 13D/G filing →
FJ Felix J. Baker 5%+ holder 13D · 15.5%	10.3M	12.90%	—	—	—	—
This holder reports through Schedule 13D/G, not a quarterly 13F. Share of the company12.900% Disclosed stake13D · 15.5% View the 13D/G filing →

Orbimed Capital GP Vi LLC

5%+ holder13D · 14.6%

11.8M

% of company

14.80%

Change vs last qtr

—

Held since

—

Felix J. Baker

5%+ holder13D · 15.5%

10.3M

% of company

12.90%

Change vs last qtr

—

Held since

—

10 more holders behind a free account

See every insider and 5%+ holder of Prelude Therapeutics Incorporated.

Comments